National Bank of Canada
FLNA

National Bank of Canada’s Filana Therapeutics FLNA Stock Holding History

National Bank of Canada’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,529
Closed -$379K – 3197
2025
Q1 		$379K Sell
2,529
-1,724
-41% -$4.35K ﹤0.01% 1379
2024
Q4 		$1M Buy
4,253
+2,935
+223% +$51.5K ﹤0.01% 1306
2024
Q3 		$3.88M Sell
1,318
-33
-2% -$760 ﹤0.01% 891
2024
Q2 		$1.64M Sell
1,351
-616
-31% -$13K ﹤0.01% 967
2024
Q1 		$3.98M Sell
1,967
-868
-31% -$20K 0.01% 857
2023
Q4 		$6.36M Sell
2,835
-372
-12% -$7.86K 0.01% 686
2023
Q3 		$5.39M Buy
+3,207
New +$63.6K 0.01% 770
2022
Q4 		– Sell
-147
Closed -$615K – 2883
2022
Q3 		$615K Sell
147
-1,240
-89% -$33.5K ﹤0.01% 1108
2022
Q2 		$3.9M Buy
1,387
+209
+18% +$5.28K 0.02% 616
2022
Q1 		$4.38M Sell
1,178
-742
-39% -$31.4K 0.01% 657
2021
Q4 		$8.39M Buy
+1,920
New +$101K 0.03% 431

Other funds holding FLNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $6.06B AUM 28.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
ML
Mayport LLC Newton, Massachusetts $645M AUM 19.45% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

National Bank of Canada's FLNA Position: Q2 2026 in Review

National Bank of Canada reduced its Filana Therapeutics (FLNA) stake by 12% in Q2 2026, selling an estimated $285 and leaving 1,510 shares worth $1.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2718.

National Bank of Canada first reported a position in FLNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $8.4M in Q4 2021. 33 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • National Bank of Canada held 1,510 shares of Filana Therapeutics worth $1.8K as of Q2 2026.
  • National Bank of Canada sold 200 Filana Therapeutics shares in Q2 2026, an estimated $285.
  • Filana Therapeutics made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2718 holding.
  • National Bank of Canada first reported a position in Filana Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's Filana Therapeutics position peaked at $8.4M in Q4 2021.
  • 33 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.